Huilan Lin | Principal Scientist
Capricor Therapeutics, Inc. |

Dr. Huilan Lin is a bioprocess development scientist with over 10 years of experience in antibody, vaccine, and exosome process development and manufacturing. His work focuses on upstream and downstream process optimization and technology transfer to GMP facilities, and he has contributed to multiple IND-enabling programs. Dr. Lin is currently a Principal Scientist at Capricor Therapeutics Inc, where he leads process development and scale-up of exosome production. Previously, he served as Senior Manager at Emergent BioSolutions, overseeing process development for protein antigen–based and viral vector–based vaccines, supporting manufacturing of Phase I clinical trial drug substance. Dr. Lin began his career in CHO cell line development and in the process development of antibody–enzyme fusion proteins for enzyme replacement therapy for rare diseases.